Standard
Four year treatment results of neovascular age-related macular degeneration with ranibizumab and causes for discontinuation of treatment. / Falk, Mads K; Kemp, Henrik; Sørensen, Torben Lykke.
In:
American Journal of Ophthalmology, Vol. 155, No. 1, 2013, p. 89-95.e3.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Falk, MK, Kemp, H
& Sørensen, TL 2013, '
Four year treatment results of neovascular age-related macular degeneration with ranibizumab and causes for discontinuation of treatment',
American Journal of Ophthalmology, vol. 155, no. 1, pp. 89-95.e3.
https://doi.org/10.1016/j.ajo.2012.06.031APA
Falk, M. K., Kemp, H.
, & Sørensen, T. L. (2013).
Four year treatment results of neovascular age-related macular degeneration with ranibizumab and causes for discontinuation of treatment.
American Journal of Ophthalmology,
155(1), 89-95.e3.
https://doi.org/10.1016/j.ajo.2012.06.031Vancouver
Falk MK, Kemp H
, Sørensen TL.
Four year treatment results of neovascular age-related macular degeneration with ranibizumab and causes for discontinuation of treatment.
American Journal of Ophthalmology. 2013;155(1):89-95.e3.
https://doi.org/10.1016/j.ajo.2012.06.031Author
Falk, Mads K ; Kemp, Henrik ; Sørensen, Torben Lykke. / Four year treatment results of neovascular age-related macular degeneration with ranibizumab and causes for discontinuation of treatment. In: American Journal of Ophthalmology. 2013 ; Vol. 155, No. 1. pp. 89-95.e3.
Bibtex
@article{6958edaf70b841f380167c34fb348bde,
title = "Four year treatment results of neovascular age-related macular degeneration with ranibizumab and causes for discontinuation of treatment",
author = "Falk, {Mads K} and Henrik Kemp and S{\o}rensen, {Torben Lykke}",
year = "2013",
doi = "10.1016/j.ajo.2012.06.031",
language = "English",
volume = "155",
pages = "89--95.e3",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier",
number = "1",
}
RIS
TY - JOUR
T1 - Four year treatment results of neovascular age-related macular degeneration with ranibizumab and causes for discontinuation of treatment
AU - Falk, Mads K
AU - Kemp, Henrik
AU - Sørensen, Torben Lykke
PY - 2013
Y1 - 2013
U2 - 10.1016/j.ajo.2012.06.031
DO - 10.1016/j.ajo.2012.06.031
M3 - Journal article
C2 - 23022167
VL - 155
SP - 89-95.e3
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
SN - 0002-9394
IS - 1
ER -
